Cardarine (GW-501516) Ultima Pharmaceuticals

£108.00

Cardarine (GW-501516) Ultima Pharmaceuticals is a PPARδ receptor agonist studied extensively in metabolic research applications. This high-purity compound for laboratory investigation only.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Cardarine (GW-501516) Ultima Pharmaceuticals
Cardarine (GW-501516) Ultima Pharmaceuticals
£108.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

GW-501516 Research Overview

Cardarine (GW-501516) is a peroxisome proliferator-activated receptor delta (PPARδ) agonist extensively studied in metabolic research applications. This compound from Ultima Pharmaceuticals represents one of the most researched PPARδ modulators available for laboratory investigation. Despite being commonly categorised alongside SARMs, GW-501516 operates through distinct receptor pathways and mechanism of action. Researchers at Stroid UK Shop have utilised this compound to investigate fatty acid oxidation pathways and cellular energy expenditure mechanisms in various experimental models.

Laboratory Applications

Scientific literature demonstrates extensive investigation of GW-501516 in metabolic pathway research, particularly focusing on PPARδ-mediated gene expression modulation. Research models have examined its effects on mitochondrial biogenesis, fatty acid β-oxidation, and glucose homeostasis mechanisms. The compound’s ability to modulate energy expenditure pathways makes it valuable for studies examining metabolic dysfunction and cellular energy utilisation. Investigators studying PPARδ receptor biology frequently employ this compound alongside other metabolic modulators. Research applications extend to exercise physiology studies, where scientists examine substrate utilisation patterns and metabolic adaptation mechanisms. The compound’s oral bioavailability in animal models facilitates administration protocols in various experimental designs, making it accessible for both SARM research protocols and broader metabolic investigations. Studies have also explored its interactions with other research compounds including peptide modulators in combination experimental frameworks.

Technical Specifications

GW-501516 Compound Profile
Parameter Specification
CAS Number 317318-70-0
Molecular Formula C₂₁H₁₈F₃NO₃S₂
Molecular Weight 453.50 g/mol
Receptor Target PPARδ agonist
Storage Conditions Room temperature, protect from light
Manufacturer Ultima Pharmaceuticals

Research Compliance

This GW-501516 product is manufactured exclusively for in-vitro laboratory research applications. The compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must possess appropriate qualifications and facilities for handling research chemicals safely. All studies should follow institutional guidelines and applicable regulatory frameworks for chemical research protocols.

Related